From: Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab
Variables in the multivariable model
Beta
Adjusted OR
95% CI
P value
PMA
0.719
2.052
1.524,2.761
< 0.001
Neutrophil count
−0.555
0.574
0.379,0.869
0.009